Cite
HARVARD Citation
Lu, P. et al. (2018). Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4. RSC advances. 8 (16), pp. 8455-8468. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lu, P. et al. (2018). Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4. RSC advances. 8 (16), pp. 8455-8468. [Online].